Hepatic steatosis/fibrosis related biomarkers in patients with metabolic dysfunction-associated steatotic liver disease
With the aggravation of hyperlipidemia, hepatic steatosis increases; with the aggravation of liver fibrosis, TG level decreases. Lipid metabolism worsens with the degree of steatosis. LDL is related to the severity of hepatic steatosis and fibrosis.
Authors
- Zijin Wang (ORCID: https://orcid.org/0000-0001-9158-4280)
- Juan Wang (ORCID: https://orcid.org/0000-0001-6027-1505)
- Xuefeng Li (ORCID: https://orcid.org/0009-0006-9806-4281)
- Zhi Peng
Institutions
- Jishou University (CN)
Publication Details
- Journal
- Biomarkers in Medicine
- Published
- 2025-11-27
- DOI
- https://doi.org/10.1080/17520363.2025.2595909
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00